IGF-1 LR3 (Long R3 IGF-1) vs MK-677 (Ibutamoren)
Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of IGF-1 LR3 (Long R3 IGF-1) and MK-677 (Ibutamoren) (also searched as MK-677 (Ibutamoren) vs IGF-1 LR3 (Long R3 IGF-1)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
IGF-1 LR3 (Long R3 IGF-1) centers on muscle, while MK-677 (Ibutamoren) leans toward muscle. On indexed research, MK-677 (Ibutamoren) is ahead (IGF-1 LR3 (Long R3 IGF-1): 14 studies, Human evidence; MK-677 (Ibutamoren): 26, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •IGF-1 LR3 (Long R3 IGF-1) is strongest for muscle; MK-677 (Ibutamoren) for muscle.
- •Evidence: IGF-1 LR3 (Long R3 IGF-1) Human evidence (14 studies) vs MK-677 (Ibutamoren) Human evidence (26).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
IGF-1 receptor agonist | Muscle growth
Ghrelin receptor agonist | Muscle mass enhancement
IGF-1 LR3 (Long R3 IGF-1) vs MK-677 (Ibutamoren): side-by-side
| Metric | IGF-1 LR3 (Long R3 IGF-1) | MK-677 (Ibutamoren) |
|---|---|---|
| Class | Muscle | Muscle |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 14 | 26 |
| Research level | Preclinical | Limited Research |
| Strongest effect | Muscle & body comp | Muscle & body comp |
| Healing & recovery | 1.0▲ | 1.0▲ |
| Muscle & body comp | 5.0▲ | 4.0 |
| Metabolic & appetite | 3.0▲ | 3.0▲ |
| Neuro & mood | 2.0▲ | 2.0▲ |
| Sleep & circadian | 0.0 | 3.0▲ |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 2.0 | 3.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | IGF-1 LR3 (Long R3 IGF-1) | MK-677 (Ibutamoren) |
|---|---|---|
| Mechanism | IGF-1 receptor agonist | Oral ghrelin-receptor agonist (GH secretagogue) |
| Route | Subcutaneous injection | Oral |
| Half-life | ~20-30 hours | ~4–6 h |
| Duration of action | — | Daily dosing |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is IGF-1 LR3 (Long R3 IGF-1)?
IGF-1 LR3 is a long-acting synthetic IGF-1 analog with reduced binding-protein affinity, used as a research-grade IGF-1 receptor agonist studied for muscle and tissue growth.
Full IGF-1 LR3 (Long R3 IGF-1) profile, mechanism & studies →What is MK-677 (Ibutamoren)?
MK-677, also known as Ibutamoren, is a growth hormone secretagogue that has garnered attention for its potential effects on muscle mass and body composition. Research is ongoing to better understand its mechanisms and applications in various contexts, including its detection in biological samples.
Full MK-677 (Ibutamoren) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~1.0/5 |
| Muscle | IGF-1 LR3 (Long R3 IGF-1) | 5.0/5 effect signal |
| Metabolic | Even | Both ~3.0/5 |
| Neuro | Even | Both ~2.0/5 |
| Sleep | MK-677 (Ibutamoren) | 3.0/5 effect signal |
| Inflammation | Even | Both ~1.0/5 |
| Skin | MK-677 (Ibutamoren) | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack IGF-1 LR3 (Long R3 IGF-1) and MK-677 (Ibutamoren)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
IGF-1 LR3 (Long R3 IGF-1) vs MK-677 (Ibutamoren): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
IGF-1 LR3 (Long R3 IGF-1) has 14 approved studies indexed (Human evidence), and MK-677 (Ibutamoren) has 26 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is IGF-1 LR3 (Long R3 IGF-1) or MK-677 (Ibutamoren) better?
It depends on your goal. IGF-1 LR3 (Long R3 IGF-1) is strongest for muscle; MK-677 (Ibutamoren) for muscle. MK-677 (Ibutamoren) has more indexed studies (26). See the goal-by-goal breakdown above.
Is IGF-1 LR3 (Long R3 IGF-1) or MK-677 (Ibutamoren) better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is IGF-1 LR3 (Long R3 IGF-1) or MK-677 (Ibutamoren) better for muscle?
IGF-1 LR3 (Long R3 IGF-1) leads on the muscle & body-composition axis (5.0/5).
Which has more research, IGF-1 LR3 (Long R3 IGF-1) or MK-677 (Ibutamoren)?
IGF-1 LR3 (Long R3 IGF-1) has 14 approved studies indexed (Human evidence); MK-677 (Ibutamoren) has 26 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack IGF-1 LR3 (Long R3 IGF-1) and MK-677 (Ibutamoren)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of IGF-1 LR3 (Long R3 IGF-1) vs MK-677 (Ibutamoren)?
IGF-1 LR3 (Long R3 IGF-1): no community-reported effects logged yet. MK-677 (Ibutamoren): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is IGF-1 LR3 (Long R3 IGF-1) or MK-677 (Ibutamoren) FDA-approved?
IGF-1 LR3 (Long R3 IGF-1) is a research-use compound and is not FDA-approved. MK-677 (Ibutamoren) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is MK-677 (Ibutamoren) better than IGF-1 LR3 (Long R3 IGF-1)?
For muscle, MK-677 (Ibutamoren) has the edge; for muscle, IGF-1 LR3 (Long R3 IGF-1) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
IGF-1 LR3 (Long R3 IGF-1) and MK-677 (Ibutamoren) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.